Thalassemias

(Anemia ya Mediterania; Thalasemia Kuu na Ndogo)

NaGloria F. Gerber, MD, Johns Hopkins School of Medicine, Division of Hematology
Imepitiwa/Imerekebishwa Apr 2024

Thalassemias are a group of inherited disorders resulting from an imbalance in the production of one of the 4 chains of amino acids that make up hemoglobin (the oxygen-carrying protein found in red blood cells).

  • Symptoms depend on the type of thalassemia.

  • Some people have jaundice and abdominal fullness or discomfort.

  • Diagnosis usually requires special hemoglobin tests.

  • Mild thalassemia may not require treatment, but severe thalassemia may require bone marrow transplantation.

(See also Overview of Anemia.)

Hemoglobin is made up of 2 pairs of globin chains. Normally, adults have 1 pair of alpha chains and 1 pair of beta chains. Sometimes one or more of these chains is decreased. Thalassemias are categorized according to the affected chain. The 2 main types are

  • Alpha-thalassemia (the alpha globin chain is affected)

  • Beta-thalassemia (the beta globin chain is affected)

Alpha-thalassemia is most common in people with African or Black American, Mediterranean, or Southeast Asian ancestry. Beta-thalassemia is most common in people of Mediterranean, Middle Eastern, Southeast Asian, or Indian ancestry.

Thalassemias can be classified according to how severe they are.

  • Thalassemia minor: Causes no symptoms or mild symptoms

  • Thalassemia intermedia: Causes symptoms that are between mild and severe

  • Thalassemia major: Causes severe symptoms that require treatment

Dalili ya Thalassemias

All thalassemias have similar symptoms, but they vary in severity.

In alpha-thalassemia minor and beta-thalassemia minor, people have mild anemia with no symptoms.

In alpha-thalassemia major, people have moderate or severe symptoms of anemia, including fatigue, shortness of breath, paleness, and an enlarged spleen, which leads to a feeling of fullness and abdominal discomfort.

In beta-thalassemia major (sometimes called Cooley anemia), people have severe symptoms of anemia, such as fatigue, weakness, and shortness of breath, and they may also have jaundice, causing yellowing of the skin and whites of the eyes, skin ulcers, and gallstones. People may also have an enlarged spleen. Overactive bone marrow may cause some bones, especially those in the head and face, to thicken and enlarge. The long bones in the arms and legs may weaken and fracture easily.

Children who have beta-thalassemia major may grow more slowly and reach puberty later than they normally would. Because iron absorption may be increased and frequent blood transfusions (providing even more iron) are needed, excessive iron may accumulate and be deposited in the heart muscle, eventually causing iron overload disease with liver damage, heart failure, and early death.

Utambuzi wa Thalassemias

  • Blood tests

  • Hemoglobin electrophoresis

  • Prenatal testing

Blood tests are done for diagnosis of thalassemia. Doctors measure blood counts and examine a sample of blood under a microscope. Characteristic abnormalities of the red blood cells can be seen.

Hemoglobin electrophoresis, another blood test, is also done. In electrophoresis, an electrical current is used to separate the different types of hemoglobin and thus detect abnormal hemoglobin. Testing a drop of blood by electrophoresis is helpful but may be inconclusive, especially for alpha-thalassemia. Therefore, the diagnosis is usually based on genetic tests and determination of hereditary patterns.

Genetic testing can be done to detect thalassemias before birth.

Matibabu ya Thalassemias

  • Sometimes blood transfusions, removal of the spleen, or iron chelation therapy

  • Stem cell transplantation

People who have a mild thalassemia do not need treatment.

People who have more severe thalassemia may need to have surgery to remove the spleen (splenectomy), blood transfusions, or iron chelation therapy. In chelation therapy, excess iron is removed from the blood. Medications called iron chelators may be given by mouth (deferasirox or deferiprone) or by an infusion (deferoxamine), which can be given under the skin (subcutaneous) or into a vein (intravenous).

Luspatercept may be given to reduce the need for blood transfusions in people with beta-thalassemia.

Some people who have a severe form of thalassemia may need stem cell transplantation.

Taarifa Zaidi

The following English-language resource may be useful. Please note that THE MANUAL is not responsible for the content of this resource.

  1. Cooley's Anemia Foundation: provides education on diagnosis and treatment as well as support for people with thalassemias